Memory Loss? Elevated Blood Sugar?

A clinical research study is currently evaluating an investigational drug for its safety and effectiveness in slowing further memory loss in patients with mild Alzheimer’s disease who also have elevated blood sugar or Type 2 diabetes.

See if you may qualify by answering a few questions right now.

So Far – So Good...

You appear to meet the pre-screening requirements for the Elevage Study!

However, only the research study staff can fully determine if you qualify to enroll in the study. Please enter your information and a study representative will contact you soon.

Sorry, you are not eligible at this time...

Thank you so much for your interest in the Elevage Study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information to be contacted about future clinical research opportunities.

Question 1 of 4

Are you between 50-85 years of age?

Question 2 of 4

Are you currently taking medication for memory loss?

Question 3 of 4

Do you have elevated blood sugar or Type 2 Diabetes?

Question 4 of 4

Do you have a reliable caregiver or study partner?

Why Participate?

Why Participate in this Important Trial?

By seeking to participate in the Elevage Study, you are being proactive by joining efforts to try to better understand Alzheimer’s disease. Your participation will help to see if azeliragon, the study drug, slows the progression of memory loss in patients with mild Alzheimer’s disease and elevated blood sugar or Type 2 diabetes. Additionally, the knowledge gained from this study may help others with Alzheimer’s disease in the future.

Eligible participants will receive study related tests at no cost, including study medication and memory assessments at each visit during the duration of the study.

The clinical research team will discuss all potential study risks with you and answer any additional questions you may have.

See If You May Qualify! Begin
Header Image

About the Study

Is This Study Right for You?

During the Elevage Study, you will be asked to:

  • Attend all study visits with your caregiver or study partner (spouse, close relative, or someone else who is knowledgeable about your daily activities).
  • Take your study medication every day as instructed.
  • Continue to take your regular memory medication as you normally do.
  • Tell the doctor in charge of this study about any changes to your health or medications for the duration of the study.
  • You will be asked to complete memory assessments during your study visits.
See If You May Qualify! Begin
Header Image

About alzheimer’s

What is Alzheimer’s Disease?

Alzheimer’s disease is a condition characterized by a progressive loss of memory, thinking, language, and behavior. It is the most common form of dementia, or loss of brain function, and represents the sixth leading cause of death in the United States. Contrary to popular belief, Alzheimer’s disease is not a normal consequence of aging.

The disease attacks the brain’s nerve cells, or neurons, which then break connections with other nerve cells. These nerve cells ultimately die. The disease begins with the loss of short-term memory and progresses with the decline of language and behavioral skills as the disease advances. There is no cure for Alzheimer’s disease.

Over 5 million adults have Alzheimer’s disease in the United States. These numbers are expected to double by 2050 (Source: 2019 Alzheimer’s Disease Facts and Figures, Alzheimer’s Association)

Other helpful resources:

See If You May Qualify! Begin
Header Image

About Azeliragon

About Elevage and Azeliragon

Azeliragon, developed by vTv Therapeutics LLC, is an investigational medication. Azeliragon works by blocking a receptor in the brain that is thought to contribute to many different causes of Alzheimer’s disease. By blocking this receptor, the progression of Alzheimer’s disease may possibly be slowed.

The Elevage Study consists of two studies. Part 1 will be conducted first and enroll approximately 100 participants. Participation will last approximately 11 months and will involve up to 2 months for screening, 6 months of study drug dosing, and 3 months of follow-up. Part 2 will be conducted only after Part 1 is completed and results are known.

See If You May Qualify! Begin
Header Image

Clinical Trials

What are Clinical Trials?

Clinical trials like the Elevage Study are research studies conducted and managed closely by physicians to determine whether new treatments are both safe and effective. They are the best way for researchers to find new ways to detect, treat, and, hopefully, find a cure or to prevent Alzheimer’s disease. Most treatments and procedures used today are the result of past clinical studies.

Participating in the Elevage Study will give you the opportunity to help determine if a new investigational medication, azeliragon, slows the progression of symptoms in Alzheimer’s disease.

See If You May Qualify! Begin